To determine whether the hENT1 × dCK/RRM1 × RRM2 ratio correlated with gemcitabine sensitivity, we examined the relative mRNA expression of hENT1, dCK, RRM1, and RRM2 to GAPDH in eight human pancreatic cancer cell lines. The gene discussed is RRM1; the disease is familial pancreatic carcinoma.